Uploaded by MilkenInstitute on Sep 21, 2011
The United States is still the global leader in the biomedical industry, but countries across Europe and Asia are pursuing aggressive plans to close the gap and take the high-value jobs and capital this sector creates. To protect its leadership position, U.S. policymakers need to take a series of actions.
The stakes are high: The biomedical sector directly and indirectly accounts for some 5 million U.S. jobs (including 1.2 million high-wage private-sector jobs in pharmaceuticals, biotech, medical devices, research and testing). Multiple factors leave the U.S. vulnerable to growing international competition: increasing complexity and uncertainty in the FDA's approval processes, especially as these relate to medical devices; government funding cuts; and federal tax policies that are not globally competitive.
European and Asian nations are investing heavily in research as well as improving access to capital for biotech start-ups. They are also taking a page from the U.S. playbook as they standardize their regulatory regimes and offer better incentives for innovation.
Beyond the established biopharmaceutical leaders in Europe and Japan, China, India and Singapore are making impressive strides in building their capacity for research, clinical testing and manufacturing. The world's best scientific talent traditionally flocked to the U.S., but today these highly prized knowledge workers are finding new job opportunities at home.
U.S. policymakers must take these seven decisive steps for the nation to retain its lead in biomedical innovation:
Increase R&D tax incentives and make them permanent
Cut corporate tax rates to match the OECD average
Enhance support for emerging fields
Provide adequate resources for the FDA and the NIH
Leverage existing strengths in medical devices
Build human capital
Promote and expand the role of universities
"The Global Biomedical Industry: Preserving U.S. Leadership" was funded in part by a grant from the Council for American Medical Innovation. The views expressed in the report are solely those of the Milken Institute.
The location of this report can be found here: http://www.milkeninstitute.org/publications/publications.taf?function=detail&...
1:22:51
forum1 22 09by MilkenInstitute9 views
1:20:25
Taking Liberties: The War on Terror and the Erosion of Democracyby MilkenInstitute85 views
1:15:27
The Comeback: How Innovation Will Restore the American Dreamby MilkenInstitute91 views
3:21
Mary Sue Milliken and Susan Feniger on Restoring California's Promiseby MilkenInstitute46 views
5:42
Why China Is Becoming So Successfulby EdgePerspectives690 views
3:01
Go China! - The 1st and Only Complete Training Programme for the China Marketby stuartchng648 views
14:10
Collapse (Part 4)by indoz003,913 views
2:40
Quebec - Canadaby THEWORLDOFTRAVEL1,967 views
4:16
MSc in Pharmaceutical Sciencesby KUfarmaceut1,756 views
3:40
What is Medical Tourism? - Cafferty Report CNNby medtourconnect307 views
13:15
Innovation or imitation in China and India?by INSEADofficial1,279 views
9:58
BBSRC Sustainable Bioenergy Centre launch 27 January 2009by bbsrcmedia2,211 views
3:43
JIKE Biotech Group in Malaysia, China and Singapore.by jikebiotech114 views
1:57
Taiwan OCAC: Taiwan's Orchids Bloomby taiwanmactv699 views
2:49
Retailing Industry Leaders Highlight 2011 Global Retailing Conferenceby uanews612 views
6:39
The Biotech Industry in China - Mr Rong He, Head of China Medical Citys Delegationby BIOchannel253 views
1:36
Higher Nitec in Biotechnologyby ITEvidz4,312 views
8:40
#GC2011: James Barth of Milken Instituteby smartbrief27 views
0:41
Ngee Ann Poly students break new ground in medical therapyby NewsSingapore232 views
1:15:49
ARI ASIA TRENDS 2010 - Lifelines: The Ethics of Blood Banking for Family and Beyondby NUScast879 views
- Loading more suggestions...
All Comments